There are significant opportunities for both military and first responder customers, across both the respiratory and head product portfolios to drive sustainable growth over the medium term.

We have a clear strategy to generate long-term earnings growth through maximising the opportunity from our current portfolio and selective product development to maintain our technology leadership position. Our strong financial position and cash generation will allow us to enhance the returns from our organic strategy with additional value enhancing acquisitions, whilst maintaining a progressive dividend policy.

010AVP-Protection-Website-Update-2021-why_invest_1.png 010AVP-Protection-Website-Update-2021-why_invest.png